Atlas Trials

The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs

Clinical trial NCT05202275 · UNKNOWN

Trial details

NCT number
NCT05202275
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NauseaVomitingHead and Neck Squamous Cell CarcinomaRadiotherapy Side Effect
Start date
2020-12-01
Primary completion
2022-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.